J, K., U, M., & H, S. (2012). Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure. Dove Medical Press.
Style de citation Chicago (17e éd.)J, Kekow, Mueller-Ladner U, et Schulze-Koops H. Rituximab Is More Effective than Second Anti-TNF Therapy in Rheumatoid Arthritis Patients and Previous TNFα Blocker Failure. Dove Medical Press, 2012.
Style de citation MLA (8e éd.)J, Kekow, et al. Rituximab Is More Effective than Second Anti-TNF Therapy in Rheumatoid Arthritis Patients and Previous TNFα Blocker Failure. Dove Medical Press, 2012.
Attention : ces citations peuvent ne pas être correctes à 100%.